Long-term cardiac effect of sacubitril-valsartan in hemodialysis patients with a reduced ejection fraction after aortic valve replacement for aortic stenosis: a case report with literature review

Table 1 Use of sacubitril-valsartan in hemodialysis patients: literature review

No	First author [ref. no.]	Year	No. of patients	Changes in N-terminal pro-brain natriuretic peptide levels		Echocardiographic findings	Ejection fraction (%)			Duration of treatment
No	First author [ref. no.]	Year	No. of patients		Duration of treatment	Echocardiographic findings	Pre	Post	p	Duration of treatment
1	Heyse A [5]	2019	1	Decrease	3 months	Improve	N/A
2	Lee S [6]	2020	23	N/A		Improve	29.7 ± 4.4	40.8 ± 10.4	0.002	132 days (median)
3	Lihua W [7]	2021	110	Decrease	12 months	Improve	35.1	49.8	< 0.001	12 months
4	Daimon S [8]	2022	7	Decrease	4 weeks	Improve	46.1 ± 7.9	55.9 ± 6.6	0.063	4 to 12 weeks
5	Wen Y [9]	2022	54	N/A		Improve	N/A
6	Feng Y [10]	2022	1	N/A		Improve	18	60		3 months

ISSN: 2059-1381